I just can't wait for all the Chinese "drug" companies to provide their new miracle formulations for treating the incurable. I see a lot a lead in their formulations along with concrete dust.
Did you purposely forget to mention the 32,000 wounded who continue to suffer every day from the Federal Reserve War?
ANDOVER — Eisai Inc., a Japanese pharmaceutical company with a 150,000-square-foot facility at 4 Corporate Drive, is laying off 72 local employees and closing one of its research divisions in town.
The company, which makes health care products including cancer and Alzheimer’s drugs, opened a $65 million, state-of-the-art lab on Corporate Drive six years ago.
That facility was meant to house employees from two different facilities - one in Wilmington and the other in a nearby building in Andover. Some 240 people now work at the combined Andover plant.
The layoff of nearly 30 percent of Eisai’s local workforce was announced in a letter late last month to the Andover Board of Selectmen from the company’s human resources department in Woodcliff Lake, N.J.
“This is part of a reorganization plan that will include the closing of its pilot plant, the reduction of a significant portion of the Pharmaceutical Science and Technology Core Function Unit in Andover, and workforce reductions in other Andover departments,” the letter said. “These actions are expected to be permanent.”
By law, companies intending to make large-scale layoffs are required to inform local authorities in advance.
The layoffs are expected to take effect Dec. 31, 2013.
A spokeswoman for Eisai, Suzanne Grogan, said this week that it’s not just Andover that’s being affected. She said 7 percent of Eisai’s global research and development organization is also affected.
“We are always looking at ways of strengthening our capabilities,” she said. “This is part of our periodic evaluation of our resources. We have to make sure we have our resources allocated to our key projects.”
She said Andover would continue to be a hub for discovery research.
The company employs about 10,500 people worldwide. In the U.S., there are about 1,500 Eisai employees and another 300 working for Eisai subsidiaries. Worldwide, the Japanese company employs more than 10,000 people. Last year Eisai had sales of nearly $6 billion.
Is this really the building that SRPT bought for only $15,000.000.00? What a steal. That fact that it was a pilot plant would most likely be a plus for Sarepta. So all the shorts should be shorting Eisai and covering SRPT.
We all know it won't work that way.
Just for the heck of it, up or down tomorrow on this news. I do realize that rational thoughts about the price of SRPT are irrational.
It has been a long time that started with Supergen and then Avii. Supergen (Astex) got bought out by Otsuka for a really cheap price and new technology finally allowed Sarepta to really see and figure out how to make the work of many brilliant men work the way they suspected it would. The non-biologic backbone as opposed to off frame reading from modified biologic's was one of the main reasons I stayed around so long.
SPPI is another great little company who's time has come even after years of abuse by the short thugs that abuse all the biotech companies. It's time has come, and unlike SRPT, it is a money making' profitable company with a very exciting pipeline. They have some new experienced sales managers from large pharma, and some really talented new leadership to help build on what Raj has put together. They have also acquired some great drug chemistry and product distribution rights from Eisai.
Are you really that upset that SRPT only paid 15 million for a small batch manufacturing & research facility that Eisai paid 65 million dollars for in 2007? Are you short at $34.50 like John Kelly?
All those involved in the secondary offering shorted it. That is one of the reasons it was pushed through at $38.00.
I don't think so, and neither will you if you compare it to the NBI. Use the 1 minute time frame.
THERE IS NO AVI.! NADA. I hope you are not paid your 10 cents per post for every time you use the name of a company that does not exist.
Have you ever thought that the building could be used for other drugs in the pipeline. Stop thinking it is DMD only!
But here you are trying to put a negative spin on Sarepta once again. Pawn your car and short another 10 shares.
That; my multiple personality friend, is not the question you should be asking. You should be asking Carl or Michael why you only get paid 10 cents for every post you make on Yahoo, while they are making hundreds of thousands of dollars manipulating share price in order to re-price options.